María del Carmen
Chillón Santos
Investigadora desde 2011
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (8)
2019
-
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation
Annals of Hematology, Vol. 98, Núm. 9, pp. 2151-2162
2018
-
Focal adhesion genes refine the intermediate-risk cytogenetic classification of acute myeloid leukemia
Cancers, Vol. 10, Núm. 11
-
Unraveling the heterogeneity of IgM monoclonal gammopathies: a gene mutational and gene expression study
Annals of Hematology, Vol. 97, Núm. 3, pp. 475-484
2015
2013
-
Evaluating gene expression profiling by quantitative polymerase chain reaction to develop a clinically feasible test for outcome prediction in multiple myeloma
British Journal of Haematology, Vol. 163, Núm. 2, pp. 223-234
-
HLA specificities are related to development and prognosis of diffuse large B-cell lymphoma
Blood, Vol. 122, Núm. 8, pp. 1448-1454
-
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström's macroglobulinemia
Leukemia, Vol. 27, Núm. 8, pp. 1722-1728
2012
-
Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: Antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype
American Journal of Pathology, Vol. 181, Núm. 5, pp. 1879-1888